1109 Clinical and laboratory manifestations of SLE patients with elevated cell-bound complement activation products

• John Conklin,
• Rebecca E Sadun,
• Kai Sun,
• Amanda M Eudy,
• Roberta Vezza Alexander,
• Lisa G Criscione-Schreiber,
• Megan EB Clowse,
• David Pisetsky,
• Jennifer L Rogers,
• Jayanth Doss,
• Rory Bloch

Affiliations

John Conklin

Exagen Inc, Vista, California, USA

Rebecca E Sadun

1 Division of Rheumatology, Department of Medicine, Duke Health, Durham, North Carolina, USA

Kai Sun

Baotou Central Hospital, Baotou, Inner Mongolia, China

Amanda M Eudy

Duke University School of Medicine, Durham, North Carolina, USA

Roberta Vezza Alexander

Exagen Inc, Vista, California, USA

Lisa G Criscione-Schreiber

1 Division of Rheumatology, Department of Medicine, Duke Health, Durham, North Carolina, USA

Megan EB Clowse

Duke University School of Medicine, Durham, North Carolina, USA

David Pisetsky

2Department of Medicine, Division of Rheumatology, Durham VA Medical Center and Duke University Medical Center, Durham, North Carolina, USA

Jennifer L Rogers

Duke University

Jayanth Doss

Duke University

Rory Bloch

2Exagen Inc, USA